CLINICAL_TRIALS
research
· 2015-04-09
Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of PCV Chemotherapy in Patients With Recurrent High-grade Glioma With IDH1/2 Mutation [NA]
Summary
Clinical trial update on the PCV chemotherapy regimen for patients with recurrent high-grade glioma harboring IDH1/2 mutations, assessing safety and effectivene…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hebei Yanda Hospital | Conditions: Recurrent High-grade Glioma | NA | Status: UNKNOWN